Frequently Asked Questions
The cost of different fertility services can vary based on the specific services and the location of the fertility centre. It is best to consult with a fertility specialist to get an accurate estimate of the costs associated with the services you may need.
Infertility testing is quite simple, and the cost can vary depending on the specific tests required and the location of the fertility centre. On average, it can range from INR 1000 to INR 5000.
IVF is considered an expensive treatment due to the complex procedures and laboratory techniques involved. The cost of IVF includes ovarian stimulation medications, egg retrieval procedures, laboratory fees for fertilisation and embryo culture, and embryo transfer procedures.
In addition to the cost of the fertility treatment itself, there may be additional expenses to consider. These can include medications, consultations with fertility specialists, additional diagnostic tests, genetic testing, and any necessary surgical procedures.
Insurance coverage for infertility treatments varies based on the specific policy and insurance provider. Some insurance plans offer coverage for infertility treatments, while others may have limited or no coverage. It is best to check with your coverage provider to determine your available coverage.
The coverage of egg freezing by insurance depends on the insurance provider and the policy you have taken. Some insurance plans offer coverage for fertility preservation, including egg freezing, while others may have limited or no coverage. It is best to check with your insurer to determine available coverage.
At Ferty9 Fertility Centre, we aim to make fertility treatments accessible to as many couples as possible. We accept various insurance plans to meet the diverse needs of our patients. However, it’s essential to understand that each insurance plan is unique, and coverage for infertility treatments can vary. We recommend you contact your insurer directly to determine the specifics of your coverage. Our knowledgeable and dedicated team is also available to help you understand your insurance benefits and navigate the process, ensuring you are well informed at every step.
Infertility is a medical condition that affects millions of people and couples worldwide. Many employers recognise the importance of supporting their employees in their journey towards parenthood. While infertility coverage varies from employer to employer, many companies now offer infertility benefits as part of their employee health plans. These resources may include coverage for diagnostic tests, fertility medications, and even assisted reproductive technologies such as in vitro fertilisation (IVF). Reviewing your employee benefits package or consulting with your human resources department to determine the extent of your infertility coverage is advisable.
Egg freezing, or oocyte cryopreservation, is a well-known fertility preservation technique that allows women to preserve their eggs for future use. It can be a valuable option for women who want to delay childbearing due to medical or personal reasons. Similar to infertility coverage, the availability of egg freezing benefits through your employer depends on your company’s specific policies. Some employers may include egg freezing as part of their fertility benefits, while others may not. It is essential to check with your employer or insurance provider to understand the degree of your coverage. At Ferty9 Fertility Center, we offer comprehensive egg freezing services and can guide you through the process of utilising your insurance benefits, if applicable.
Understanding the financial aspect of fertility treatments is crucial for couples who are exploring their options. At Ferty9 Fertility Centre, we offer zero cost EMI option to guarantee our patients can access the care they need without considering undue financial burden. Our dedicated financial counsellors are here to guide you every step of the way. Our goal is to provide transparency and support throughout the financial process so our patients can focus on their journey towards parenthood.
Cryopreservation is a technique used to freeze and store biological materials, such as sperm, eggs, or embryos, for future use. It is an integral component of assisted reproductive technology, offering individuals and couples the opportunity to preserve their fertility when facing factors that may compromise their reproductive capabilities. Cryopreservation has revolutionised the field of reproductive medicine, allowing for the successful preservation and utilisation of gametes and embryos.
Cryopreservation involves the careful freezing of biological materials using specialised techniques and equipment. The process typically includes the addition of cryoprotectants to protect the biological cells from damage during the freezing and thawing process. The samples are then cooled at a controlled rate and stored in liquid nitrogen at extremely low temperatures. This freezing technique effectively preserves the viability and functionality of sperm, eggs, and embryos, enabling their future use in fertility treatments.
Elective cryopreservation refers to the deliberate choice of freezing and storing embryos for future use instead of transferring them immediately during an IVF cycle. This approach provides several advantages over fresh embryo transfer. Frozen embryos have a higher chance of survival and implantation due to the ability to select the most viable embryos through PGT. Additionally, cryopreservation allows for multiple transfer attempts, increasing the overall success rates of IVF treatments. Elective cryopreservation gives individuals and couples greater flexibility in family planning and increases the chances of achieving their desired parenthood goals.
The cryopreservation technique for sperm, eggs, and embryos is a complex process. After collection, the samples undergo a process called vitrification, which involves rapid freezing in a high concentration of cryoprotectants. These cryoprotectants play a crucial role in preventing ice crystal formation, which can damage the biological cells during the freezing process. The samples are then preserved in liquid nitrogen at ultra-low temperatures until they are needed for future use. This cryopreservation technique is essential for the long-term preservation of sperm, eggs, and embryos, maintaining their viability and fertility potential.
Embryos can be safely frozen and stored for extended periods. The duration of cryopreservation depends on various factors, such as the quality of the embryos and the regulations of the fertility clinic. In many cases, one can store embryos for several years without compromising their viability or fertility potential. Fertility clinics typically have stringent protocols in place to ensure the proper storage and monitoring of frozen embryos, providing individuals and couples with the flexibility to plan their family-building journey according to their specific circumstances.
In the frozen embryo transfer (FET) procedure, cryopreserved embryos are thawed and transferred into the uterus during an IVF cycle. FET offers several advantages over fresh embryo transfer, including a higher chance of successful implantation and pregnancy. The ability to select the healthiest embryos through PGT and prepare the uterine lining for optimal receptivity contributes to the increased success rates of FET. This technique allows individuals and couples to maximise their possibilities of achieving a successful pregnancy while minimising the risks associated with multiple embryo transfer.
Preparing for a frozen embryo transfer cycle involves a series of carefully planned steps to optimise the chances of successful implantation and pregnancy. The process typically starts with hormonal therapy to prepare the uterine lining for embryo transfer. This therapy may involve administering estrogen and progesterone to mimic the natural hormonal changes during a natural menstrual cycle. The fertility clinic will closely monitor the progress of the cycle through ultrasound scans and blood tests to ensure that the uterine lining is ready for implantation. Once the optimal conditions are achieved, the surgeon thaws and transfers cryopreserved embryos into the uterus, following which the individual or couple will undergo a period of waiting to determine the outcome of the cycle.
Ovarian hyperstimulation syndrome (OHSS) is a potentially serious aftermath that can occur during fertility treatments, such as in ovarian stimulation for in vitro fertilisation (IVF). In this condition, ovaries respond excessively to fertility medications, causing fluid buildup in the abdominal cavity and, in severe instances, the chest cavity. OHSS symptoms range from mild to severe and can cause discomfort, pain, abdominal manifestations, rapid weight gain, and, in rare cases, life-threatening complications. At Ferty9 Fertility Centre, we follow mild stimulation protocol to prioritise the safety and well-being of our patients and closely monitor the development of OHSS during fertility treatments.
The symptoms of OHSS can vary from mild to severe and may include abdominal bloating, discomfort or pain, nausea, and vomiting. In severe cases, OHSS can cause rapid weight gain, decreased urine output, and shortness of breath. Fluid buildup in the chest can also result in breathing difficulties and blood clotting abnormalities. If you experience any of these symptoms during or after fertility treatment, it is crucial to seek immediate medical attention at Ferty9 Fertility Centre.
The leading cause of OHSS is the excessive use of fertility medications that activate the ovaries to produce multiple eggs. The excess production of eggs can lead to ovarian enlargement and the release of substances that cause blood vessels to seep fluid into the abdomen. Certain risk factors, such as a young age, polycystic ovary syndrome (PCOS), and a high ovarian reserve, may increase the likelihood of developing OHSS. Our experienced fertility specialists at Ferty9 Fertility Centre carefully monitor the response to fertility medications to minimise the risk of OHSS.
OHSS is relatively uncommon, occurring in approximately 1-10% of women undergoing fertility treatments, particularly IVF. However, the risk can vary depending on individual factors and the specific fertility protocol. At Ferty9 Fertility Centre, we employ personalised treatment plans and closely monitor our patients to minimise the risk of OHSS and ensure optimal outcomes.
Certain factors may increase the risk of developing OHSS, including a young age, a high ovarian reserve, polycystic ovary syndrome (PCOS), and a history of OHSS in previous fertility treatments. Additionally, the use of certain fertility medications and a robust response to ovarian stimulation can also increase the likelihood of developing OHSS. At Ferty9 Fertility Centre, our experienced fertility specialists will assess your risk factors and adjust your treatment plan accordingly to minimise the risk of OHSS.
Oncofertility is a multidisciplinary field that focuses on preserving fertility in cancer patients. Cancer treatments like chemotherapy and radiotherapy can damage reproductive organs or disrupt hormonal balance, leading to infertility or premature menopause. At Ferty9 Fertility Centre, we provide specialised oncofertility facilities to help cancer patients preserve their fertility options before undergoing cancer treatment.
Cancer can affect fertility in various ways, depending on the type and location of the cancer, as well as the treatment modalities used. Chemotherapy drugs and radiotherapy can damage the eggs or sperm, disrupt hormone production, and cause irreversible damage to the reproductive organs. At Ferty9 Fertility Centre, we understand the unique challenges faced by cancer patients and provide personalised fertility preservation options.
At Ferty9 Fertility Centre, we offer several oncofertility options to cancer patients, including egg freezing, sperm freezing, and embryo freezing. These modalities allow individuals to preserve their reproductive cells or tissues before undergoing cancer treatment. Our team of experts will guide you through the process and provide the necessary support to make informed choices about your fertility preservation options.
